Endogenous aryl hydrocarbon receptor (AhR) agonist (Ki = 3 nM). Decreases Oct4 levels in U87 glioblastoma cells. Induces stem-like cancer cell differentiation in U87 tumor spheres and inhibits ovarian cancer cell proliferation in vitro. Suppresses tumor growth in U87 and OVCAR-3 cell xenografts in mice. Also inhibits TGF-β-induced human myofibroblast differentiation.
Sold under license, US Patent Application 2002183524
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 286.3. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.49 mL||17.46 mL||34.93 mL|
|5 mM||0.7 mL||3.49 mL||6.99 mL|
|10 mM||0.35 mL||1.75 mL||3.49 mL|
|50 mM||0.07 mL||0.35 mL||0.7 mL|
References are publications that support the products' biological activity.
Song et al (2002) A ligand for the aryl hydrocarbon receptor isolated from lung. Proc.Natl.Acad.Sci.U.S.A. 99 14694 PMID: 12409613
Lehmann et al (2011) The aryl hydrocarbon receptor ligand ITE inhibits TGF beta 1-induced human myofibroblast differentiation. Am.J.Pathol. 178 1556 PMID: 21406171
Cheng et al (2015) Tryptophan derivatives regulate the transcription of Oct4 in stem-like cancer cells. Nat.Commun. 6 7209 PMID: 26059097
Wang et al (2013) An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells. Cancer Lett. 340 63 PMID: 23851185
If you know of a relevant reference for ITE, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: ITE, supplier, Endogenous, agonists, transcription, factor, aryl, hydrocarbon, receptor, AHR, Receptors, myofibroblast, differentiation, inhibits, inhibitors, stem, cells, stem-like, cancer, Aryl, hydrocarbon, receptor, ligand, Aryl, Hydrocarbon, Receptors, Cancer, Stem, Cells, Cancer, Stem, Cell, Differentiation, Aryl, Hydrocarbon, Receptors, Tocris Bioscience
4 Citations for ITE
Citations are publications that use Tocris products. Selected citations for ITE include:
Wu et al (2014) ITE and TCDD differentially regulate the vascular remodeling of rat placenta via the activation of AhR. PLoS One 9 e86549 PMID: 24475139
Wang et al (2013) An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells. Cancer Lett 340 63 PMID: 23851185
Nugent et al (2013) ITE, a novel endogenous nontoxic aryl hydrocarbon receptor ligand, efficiently suppresses EAU and T-cell-mediated immunity. PLoS One 54 7463 PMID: 24150760
Yeste et al (2012) Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 109 11270 PMID: 22745170
Do you know of a great paper that uses ITE from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)